Free Trial

Karyopharm Therapeutics (KPTI) Insider Trading & Ownership

Karyopharm Therapeutics logo
$0.73 0.00 (0.00%)
(As of 12/11/2024 ET)

Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$1.45 M
Get KPTI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KPTI Insider Buying and Selling by Quarter

Karyopharm Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2024Richard A PaulsonCEOSell3,607$0.88$3,174.16  
8/6/2024Richard A PaulsonCEOSell3,608$0.93$3,355.44  
7/30/2024Stuart PoultonEVPSell2,883$1.06$3,055.98  
7/5/2024Richard A PaulsonCEOSell3,616$0.85$3,073.60  
6/7/2024Deepika PakianathanDirectorSell231,548$0.95$219,970.60  
6/5/2024Deepika PakianathanDirectorSell468,044$0.96$449,322.24  
6/4/2024Michael MasonCFOSell652$0.99$645.48  
6/4/2024Richard A PaulsonCEOSell3,592$0.99$3,556.08  
6/3/2024Deepika PakianathanDirectorSell360,744$1.00$360,744.00  
5/31/2024Deepika PakianathanDirectorSell204,394$0.95$194,174.30  
5/6/2024Richard A PaulsonCEOSell3,576$1.13$4,040.88  
4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13  
4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.27  
3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.90  
2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41  
2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79  
2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39  
2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.90  
2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40  
2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51  
2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95  
2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08  
1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48  
(Data available from 1/1/2013 forward)

KPTI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Jatin Shah, Michael Kauffman, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sharon Shacham, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI.

4.30% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings.

The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,190.80).

Insiders have purchased a total of 41,140 KPTI shares in the last 24 months for a total of $50,190.80 bought.

The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($1,224,211.14), Michael Mano ($25,029.45), Michael Mason ($86,230.06), Reshma Rangwala ($53,692.02), Richard A Paulson ($304,191.65), Sohanya Roshan Cheng ($48,237.77), Stephen Mitchener ($19,261.71), and Stuart Poulton ($34,391.10).

Insiders have sold a total of 1,591,889 Karyopharm Therapeutics shares in the last 24 months for a total of $1,795,244.90 sold.

Karyopharm Therapeutics Key Executives

  • Mr. Richard A. Paulson M.B.A. (Age 57)
    President, CEO & Director
    Compensation: $1.43M
    3 recent trades
  • Ms. Sohanya Cheng M.B.A. (Age 41)
    Executive VP & Chief Commercial Officer
    Compensation: $742.95k
  • Mr. Stuart Poulton
    Executive VP & Chief Development Officer
    1 recent trades
  • Dr. Reshma Rangwala M.D. (Age 46)
    Ph.D., Executive VP, Chief Medical Officer & Head of Research
    Compensation: $777.32k
  • Dr. Mansoor Raza Mirza M.D. (Age 63)
    Clinical Consultant, Member of Scientific Advisory Board & Independent Director
    Compensation: $150k
  • Dr. Sharon Shacham M.B.A. (Age 54)
    Ph.D., Co-Founder & Chairman of Scientific Advisory Board
    Compensation: $1.4M
  • Mr. Cameron Peters (Age 64)
    Vice President of Finance, Assistant Treasurer & Principal Accounting Officer
  • Ms. Elhan Webb C.F.A.
    Senior Vice President of Investor Relations
  • Mr. Michael J. Mano J.D. (Age 47)
    Senior VP, General Counsel & Secretary
    Compensation: $625.08k
  • Mr. James Accumanno J.D.
    Chief Compliance Officer


This page (NASDAQ:KPTI) was last updated on 12/11/2024 by MarketBeat.com Staff
From Our Partners